Abstract:Coumarin derivatives have diverse structures and show various significant biological activities. Aiming to develop more potent coumarin derivatives for cancer treatment, a series of coumarin acrolein hybrids were designed and synthesized by using molecular hybridization approach, and investigated for their antiproliferative activity against A549, KB, Hela and MCF-7 cancer cells as well as HUVEC and LO2 human normal cells. The results indicated that most of the synthesized compounds displayed remarkable inhibitory activity towards cancer cells but low cytotoxicity on normal cells. Among all the compounds, 5d and 6e were the most promising compounds against different cancer cell lines, especially for A549 and KB cells. The preliminary action mechanism studies suggested that compound 6e , the representative compound, was capable of dose-dependently suppressing migration, invasion and inducing significant apoptosis. Furthermore, the combined results of network pharmacology and validation experiments revealed that compound 6e induced mitochondria dependent apoptosis via the PI3K/AKT-mediated Bcl-2 signaling pathway. In summary, our study indicated compound 6e could inhibit cell proliferation, migration, invasion and promote cell apoptosis through inhibition of PI3K/AKT signaling pathway in human oral epidermoid carcinoma cells. These findings demonstrated the potential of 3-(coumarin-3-yl)-acrolein derivatives as novel anticancer chemotherapeutic candidates, providing ideas for further development of drugs for clinical use.

SYNTHESIS AND ANTIPROLIFERATIVE ACTIVITY STUDY OF NOVEL COUMARIN DERIVATIVES

Synthesis and Biological Evaluation of a Novel Class of Coumarin Derivatives.

Design, Synthesis, Biological Activity and Molecular Docking Study of Coumarin Derivatives Bearing 2-Methylbiphenyl Moiety

Design, Synthesis and Biological Evaluation of Novel 3-Substituted 4-Anilino-coumarin Derivatives As Antitumor Agents

Design, Synthesis, and in Vitro Evaluation of Novel 3, 7‐disubstituted Coumarin Derivatives As Potent Anticancer Agents

Synthesis and evaluation of novel substituted 5-hydroxycoumarin and pyranocoumarin derivatives exhibiting significant antiproliferative activity against breast cancer cell lines.

Synthesis and Anticancer Evaluation of Novel Coumarin Derivatives

Synthesis, Characterization And Activity Evaluation Of Matrinic Acid Derivatives As Potential Antiproliferative Agents

Coumarin Sulfonamides and Amides Derivatives: Design, Synthesis, and Antitumor Activity In Vitro

Synthesis and Biological Evaluation of 4-(1,2,3-triazol-1-yl)coumarin Derivatives As Potential Antitumor Agents

Synthesis of coumarin derivatives and investigation of their inhibitory effects on lung cancer cell motility

Synthesis and antiproliferative evaluation of novel 3,5,8-trisubstituted coumarins against breast cancer

Synthesis and Biological Evaluation of Hydroxylated 3-Phenylcoumarins As Antioxidants and Antiproliferative Agents

Design, semi-synthesis and bioevaluation of koumine-like derivatives as potential antitumor agents in vitro and in vivo

Design, Synthesis, and Evaluation of in Vitro and in Vivo Anticancer Activity of 4-Substituted Coumarins: A Novel Class of Potent Tubulin Polymerization Inhibitors.

Synthesis and Antitumor Activities of Novel 3-Arylcoumarins

Design and Synthesis of Coumarin Derivatives as Cytotoxic Agents through PI3K/AKT Signaling Pathway Inhibition in HL60 and HepG2 Cancer Cells

Synthesis and Biological Evaluation of Coumarin Schiff Base Derivatives as Novel Antitumor Inhibitors

Design, synthesis and anticancer activity studies of 3-(coumarin-3-yl)-acrolein derivatives: Evidenced by integrating network pharmacology and vitro assay

Novel Coumarin-Dihydropyrazole Thio-Ethanone Derivatives: Design, Synthesis and Anticancer Activity.

Design, Synthesis, and Evaluation of Novel Coumarin-Dithiocarbamate Derivatives (ids) As Anti-Colorectal Cancer Agents